Blood Plasma Derivatives Market Trends, Opportunities & Competitive Landscape
The Blood Plasma Derivatives Market is expanding as healthcare providers increasingly depend on plasma-derived products for the treatment of immunological conditions, bleeding disorders, and critical illnesses. The market was valued at USD 43.3 billion in 2024 and is expected to reach USD 46.6 billion in 2025. Market Research Future forecasts that it will grow to USD 86.67 billion by 2035, at a CAGR of 6.47% during 2025–2035. The increasing prevalence of chronic diseases, growing awareness of rare disorders, and demand for specialized plasma therapies are supporting this expansion. Improvements in plasma donation, collection, fractionation, and purification processes are also helping manufacturers strengthen supply and improve product quality.
Immunology is the largest application area, reflecting the importance of plasma-derived treatments for immune deficiencies and autoimmune diseases. Oncology is the fastest-growing application as research explores additional therapeutic uses. By product type, albumin holds the leading position, while immunoglobulins are expanding fastest due to increased clinical demand. Hospitals remain the largest end-user segment, supported by their use of plasma products in surgeries, trauma care, and specialized treatment. Blood banks are growing rapidly as collection infrastructure and donor awareness improve. North America is the leading regional market, while Asia-Pacific offers substantial growth opportunities through healthcare investment and improved access to plasma-derived medicines. Prominent companies include Grifols, CSL Behring, Takeda Pharmaceutical Company Limited, Octapharma, Kedrion, Bio Products Laboratory, LFB Group, and Hualan Biological Engineering.
How much is the blood plasma derivatives market expected to be worth in 2035?
The market is projected to reach USD 86.67 billion by 2035.
Which application contributes the largest share?
Immunology is the dominant application segment.
What makes immunoglobulins an important growth category?
They are increasingly used to treat immune deficiencies and autoimmune disorders, supporting rising demand.
Which end-user segment is expanding fastest?
Blood banks are the fastest-growing end-use category.
What technological developments are influencing the market?
Advances in plasma fractionation, purification, automated collection, and processing technologies are improving efficiency and product safety.
- Art
- Causes
- Crafts
- Dance
- Drinks
- Film
- Fitness
- Food
- Jogos
- Gardening
- Health
- Início
- Literature
- Music
- Networking
- Outro
- Party
- Religion
- Shopping
- Sports
- Theater
- Wellness